Summary
Biotechnology in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Brazil
- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil biotechnology market with five year forecasts
Reasons To Buy
- What was the size of the Brazil biotechnology market by value in 2016?
- What will be the size of the Brazil biotechnology market in 2021?
- What factors are affecting the strength of competition in the Brazil biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Brazil's biotechnology market?
Key Highlights
The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
The Brazilian biotechnology market is expected to generate total revenues of $12.0bn in 2016, representing a compound annual growth rate (CAGR) of 4.6% between 2012 and 2016.
The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $4.0bn, equivalent to 33% of the market's overall value.
In addition to a large trade deal with China, Brazil has signed agreements with Colombia following a sharp rise in trade between the two countries. Positive noises are also being made about a deal with UK, which would help the burgeoning biotechnology sector.
'
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Braskem SA
EMS S.A.
FuturaGene Plc
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
Table 1: Brazil biotechnology industry value: $ billion, 2012-16(e)
Table 2: Brazil biotechnology industry category segmentation: $ billion, 2016(e)
Table 3: Brazil biotechnology industry geography segmentation: $ billion, 2016(e)
Table 4: Brazil biotechnology industry value forecast: $ billion, 2016-21
Table 5: Braskem SA: key facts
Table 6: Braskem SA: key financials ($)
Table 7: Braskem SA: key financials (BRL)
Table 8: Braskem SA: key financial ratios
Table 9: EMS S.A.: key facts
Table 10: FuturaGene Plc: key facts
Table 11: Sanofi SA: key facts
Table 12: Sanofi SA: key financials ($)
Table 13: Sanofi SA: key financials (€)
Table 14: Sanofi SA: key financial ratios
Table 15: Brazil size of population (million), 2012-16
Table 16: Brazil gdp (constant 2005 prices, $ billion), 2012-16
Table 17: Brazil gdp (current prices, $ billion), 2012-16
Table 18: Brazil inflation, 2012-16
Table 19: Brazil consumer price index (absolute), 2012-16
Table 20: Brazil exchange rate, 2012-16
Braskem SA
EMS S.A.
FuturaGene Plc
Sanofi SA
